SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " IAS " 1,403 found 🔀 AI-powered Shuffle
Norma Izzo Named Among AZ Big Media’s Most Influential Women in Arizona Business for 2026
Spencer Fane is pleased to announce attorney Norma Izzo has been named one of AZ Big Media’s Most Influential Women in Arizona Business for 2026, an honor
2. Bundesliga preview: Hertha BSC vs. 1. FC Heidenheim
After both sides began their respective campaigns with victories, albeit with seemingly different ambitions for the season ahead, Hertha BSC and Heidenheim will lock horns at the Olympiastadion on Sat...
Sporting Lisbon Makes Luis Suarez Decision Amid Newcastle Transfer Links
Newcastle United continues to be linked with attacking reinforcements as Matthias Jaissle shapes his squad for the new Premier League season. One of the Magpies’ previously reported targets, Sporting Lisbon striker Luis Suarez, has resurfaced amid uncertainty in Portugal. Following some worrying developments surrounding his situation in the Iberian club, Portuguese outlet A Bola reports […]
Bengals news: Joe Burrow reacts to Jayden Daniels-LSU fiasco
Bengals star Joe Burrow, who also hails from LSU, was asked about his thoughts on Jayden Daniels' legal battle with their alma mater.
Blues 'enthusiast' Morgan Freeman's album covers 100 years of the genre
Academy Award-winning actor Morgan Freeman emphasizes the importance of keeping the blues alive, calling it “America’s music.”
Why This Shark Glows in the Dark—and What Scientists Just Discovered About It - Futura-Sciences
The Glow of the Kitefin Shark The kitefin shark (Dalatias licha) is a master of the twilight zone, cruising the deep-sea gloom like a spectral submarine. Like many marine creatures, it produces its own blue-green light. Until recently, scientists believed this bioluminescence mainly helped the shark perform what’s called “counter-illumination”—by...
Michigan cyclosporiasis outbreak tops 13,900 cases; 35 additional hospitalizations in past week
An additional 35 Michigan residents have required hospital care for cyclosporiasis as an outbreak continues to be tracked, state health officials said on Thursday.
How Lisa Demuth’s Republican rivals gave her a lane in the governor’s race
Plus: DFLers are winning the enthusiasm race.
Former SPLC official charged in Justice Department's broader criminal case against group
A former Southern Poverty Law Center official has been charged in the Department of Justice’s broader criminal case against the Alabama-based civil rights group, a frequent target of conservative critics who claim the nonprofit is politically biased.
Wildlife experts share new details on Jackie the bald eagle’s health before her death
As the Big Bear community and wildlife enthusiasts around the world continue to mourn the death of Jackie, many still have questions about what happened to the famous bald eagle and what’s ne…
Why is climate action “easier said than done”? The key lies in the strong coupling between climate and society
A new Perspective in Science Bulletin argues that the persistent gap between climate science and climate action stems from a conceptual blind spot: treating climate and social systems as separate domains rather than as one integrated, co-evolving entity. The authors introduce the Climate-Social Coupling System (CSS) paradigm and, by re-contextualizing the classic Environmental Kuznets Curve, sort national trajectories into “strong,” “weak,” and “de-coupling” states, showing that governance is the decisive, reversible steering mechanism that determines a country’s climate future.
Advancing the science of dietary nitrate with integrated vascular assessment
Standardised beetroot-derived dietary nitrate supports endothelial function, arterial compliance, central haemodynamics and nitric oxide bioavailability, thereby promoting systems-based research in vascular nutrition
State health officials report 906 cyclosporiasis cases since May, with 39 new since Aug. 4
The North Carolina Department of Health and Human Services has reported 906 cases of cyclosporiasis since May, according to the latest data on their website.The
Oklahoma Health Department reports 506 cyclosporiasis cases statewide
The Oklahoma State Department of Health has updated the cyclosporiasis numbers in Oklahoma, with 496 confirmed cases and 10 probable cases as of Tuesday, Aug. 1
‘Real mummy’s curse’: health warning over growing trade in mummified human remains
Academic paper says often illicit trade exposes enthusiasts – and postal workers handling items – to serious risks
Lallemand Bio-Ingredients to spotlight science-driven ingredients at Vitafoods Asia 2026
Lallemand Bio-Ingredients, Health Ingredients, a global leader in fermented functional ingredients for human health and nutrition, will showcase its latest science-backed ingredients at Vitafoods Asia 2026, taking place September 2-4, 2026, in Bangkok, Thailand
Kings’ perfect trade target amid 2026 NHL Free Agency
Kings eye Elias Pettersson trade to fill center void, but Canucks' cap hit and no-movement clause complicate a 2026 offseason deal.
AbCellera women’s health data top ‘most aggressive upside scenario,’ putting Astellas and Bayer on notice
AbCellera has reported phase 2 results “beyond even the most aggressive upside scenario” that its CEO dared to consider, boosting the biotech’s chances of challenging Astellas and Bayer for a women’s health market. The phase 2 clinical trial compared ABCL635, an antibody targeting NK3R, to placebo in patients with hot flashes caused by menopause. Investigators enrolled 92 postmenopausal women experiencing a mean of about 10 moderate or severe hot flashes per day. By Week 4, the number of moderate or severe hot flashes had fallen by a mean of 8.8 on ABCL635 and by 3.5 on placebo. That statistically significant, placebo-adjusted reduction of 5.3 hit the trial’s primary endpoint. The level of efficacy also cleared the bar set by existing drugs. While cross-trial comparisons can be misleading, AbCellera CEO Carl Hansen, Ph.D., had seen enough to start hyping the program. “We now view ABCL635 as a potential best-in-class non-hormonal therapy with strong differentiation against approved NK3R competitors across all important dimensions, including efficacy, safety, dosing and convenience,” Hansen said on a Monday morning conference call with investors to discuss the data. “We believe ABCL635 is now a highly de-risked program.” Last week, Hansen used AbCellera’s earnings call to set expectations for readout, with the CEO defining success as a clean safety profile and efficacy comparable to the two approved small molecules. The data vaulted over that bar. Astellas linked (PDF) one of the small molecules, Veozah, to placebo-adjusted reductions in hot flash frequency of 2.1 and 2.6 at Week 4 of its two phase 3 trials. Bayer reported (PDF) placebo-adjusted reductions of 3.04 and 3.29 at Week 4 of pivotal studies for its small molecule, Lynkuet. At 5.3, the placebo-adjusted reduction in AbCellera’s trial comfortably cleared the standard set by the incumbents. Veozah and Lynkuet came to market based on evidence of their ability to reduce the frequency and severity of hot flashes. AbCellera’s phase 2 study covered both endpoints, with the Canadian biotech reporting a mean reduction in severity of 1.4 points at Week 4 on ABCL635, compared to 0.3 points for placebo. Again, the placebo-adjusted result compares favorably to data on Veozah and Lynkuet. Analysts shared Hansen’s enthusiasm for the data. The phase 2 results “firmly validate ABCL635 as a potentially best-in-class treatment,” BMO Capital Markets analysts said in a note to investors Monday. ABCL635’s apparent efficacy edge “is likely attributable to the higher dosing/target engagement the asset is able to reach vs. the oral agents due to its wider therapeutic index,” the analysts added. The analysts, who model $2.3 billion in unadjusted peak sales for ABCL635, flagged the safety profile as another positive of the phase 2 readout. While Veozah carries a boxed warning for liver damage, nobody on ABCL635 in the phase 2 trial had elevated liver enzymes or bilirubin values. If replicated in phase 3, the lack of a liver signal could allow approval without the monitoring requirements imposed on Veozah. Investors appeared equally enthused, sending AbCellera's stock up 32% to $9.21 in premarket trading Monday from a Friday closing price of $6.93. Next, AbCellera will collect the Week 12 data and talk to its advisors about further development. The results open up “a wide variety of possibilities of how we might take this forward into phase 3 studies to truly maximize the value of the asset and make sure that ABCL635 is able to demonstrate its differentiation potential,” Sarah Noonberg, M.D., Ph.D., AbCellera’s chief medical officer, told investors.
Cynopsis 8/10/2026: The Media And Entertainment Industry Is Creating Jobs
Monday, August 10, 2026 Happy Monday, readers! Today’s newsletter includes: A Hollywood-Shaped Silver Lining In July’s Jobs Report So Much
Ford Frenzy brings Bronco showcase, food drive and entertainment to Charleston
CHARLESTON, W.Va. (WOWK) – Automotive enthusiasts and families gathered at Capitol Ford in Charleston this weekend for Ford Frenzy, a two-day community event featuring Broncos, local vendors,…
Jordan Health hosts Front Porch Festival, Health Fair for Community Health Center Week
Jordan Health held its annual Front Porch Festival and Health Fair on Saturday to celebrate National Community Health Center Week.Organizers said it was a community event focused on health care, education and sharing
The Atlanta Braves Have a Raisel Iglesias Problem
The Atlanta Braves have a problem regrading closer Raisel Iglesias' performance since July 1st.
Downtown Danville’s FIRST FRIDAYS “Science in the City” Brings Out Crowd Heading into Weekend
Downtown Danville's now traditional August First Fridays event "Science in the City" brought out kids, adults, and families Friday night (Aug 7th). It's meant to build up enthusiasm for the coming school year; but also, like all First Fridays events, to give families a good time.
Jack Haven’s Little Death Is the Bloody, Beating Heart of ‘Camp Miasma’
The actor’s silent performance is the glue that binds Jane Schoenbrun’s meta slasher romance together.
In Britain, a comedy candidate plays political spoiler
The U.K. electoral system has long featured parody also-rans. But now, Britain’s foremost far-right leader could find himself upended by a man wearing a bin.
War, Erasure, and the Politics of Culture in Sudan - Georgetown Journal of International Affairs
Two millennia of inhabitation by indigenous groups, immigrant and diaspora communities, and many others who made the land their home have shaped Sudan’s cultural legacy along the two Niles. Today, over 120 languages connect Sudan’s territories and diasporas, exemplifying the country’s immense diversity as the result of its complex history. However, contemporary legislation, such as […]
Health department to discontinue cyclosporiasis hotline with fewer new cases
Lucas County has reported 1,246 cases of cyclosporiasis, while 3,229 cases have been confirmed across northwest Ohio, a regional increase of 23 since ...
Industry and academic leaders explore how engineering innovation is powering the next era of space science at the 46th COSPAR Scientific Assembly
Leading voices from across the aerospace industry and academia gathered in Florence, Italy for the panel titled "Engineering Innovation Enabling Scientific Research," examining how advances in engineering are unlocking new scientific missions and how ambitious science goals are, in turn, driving engineering breakthroughs. The panel, moderated by Alison Nordt, Director of Space Sciences & Instrumentation at Lockheed Martin Space's Advanced Technology Center, brought together six panellists to discuss the evolving relationship between space science and systems engineering: Marius Anger (Aalto University), Jon Arenberg (Northrop Grumman), Mayra Montrose (L3Harris), Giampiero Di Paolo (Thales Alenia Space Italia), Steve Squyres (Blue Origin) and Eric Stallmer (Voyager).
The best classic slasher movie you’ll never watch
From the director of I Saw the TV Glow.
Africa doesn’t just need more startups. It needs ways to help viable businesses survive
The frequent closure of African small businesses threatens the fabric of entrepreneurship on which the continent relies – but the diaspora could step in.
The noise is getting louder, which is why science matters more than ever
For brands and formulators in gut health, the rise of AI-generated misinformation makes verified science a commercial differentiator, not just a regulatory safeguard
Once discouraged, now encouraged: Former CDC official gives new reasons to believe in US healthcare
Having served almost 11 years in the C-suite of the Centers for Disease Control and Prevention, Deb Houry, MD, MPH, is now looking out over U.S. healthcare with glass-half-full enthusiasm.
California's cyclosporiasis cases are 'higher than expected,' but officials aren't sure why
There are no known cyclosporiasis outbreaks in California, but officials say case numbers are higher than they expected for this point in the season.
Money, politics, and the ‘beautiful game’: FIFA battles to win back trust
Dissent has kicked off over the future of the soccer World Cup, leading to calls for a change at FIFA.
Michigan health officials say people can resume regular lettuce-eating habits as new cases of cyclosporiasis slow
Michigan health officials said on Thursday that people can resume regular lettuce- and salad greens-eating habits as new cases of cyclosporiasis slow.
Michigan health officials say people can resume regular lettuce-eating habits as new cases of cyclosporiasis slow
Michigan health officials said on Thursday that people can resume regular lettuce- and salad greens-eating habits as new cases of cyclosporiasis slow.
Michigan health officials say people can resume regular lettuce-eating habits as new cases of cyclosporiasis slow
Michigan health officials said on Thursday that people can resume regular lettuce- and salad greens-eating habits as new cases of cyclosporiasis slow.
Michigan health officials say people can resume regular lettuce-eating habits as new cases of cyclosporiasis slow
Michigan health officials said on Thursday that people can resume regular lettuce- and salad greens-eating habits as new cases of cyclosporiasis slow.
MU Health Care discusses rising cyclosporiasis cases amid nationwide outbreak
Cyclosporiasis cases continue to rise across the United States, and MU Health Care officials discussed the ongoing outbreak during a media briefing Thursday.
Health officials say lettuce, salad greens contaminated with cyclosporiasis have left the market
Michigan health officials lift lettuce, salad greens warning as cyclosporiasis cases decline
Michigan residents can resume routine guidance on eating lettuce and salad greens, state health officials said Thursday, as cyclosporiasis cases begin to decline.
Safe to eat lettuce like normal as statewide cyclosporiasis numbers dwindle, health officials say
Health officials on Thursday said it’s safe for residents to return to typical food safety guidance as statewide cyclosporiasis numbers continue to decline.
Which type of thinker are you? + US explosive diarrhoea outbreak
Madeleine Finlay is joined by Ian Sample, Guardian science editor, to discuss three eye-catching science stories including an investigation that has identified four distinct types of thinker. Also on the agenda is the unprecedented cyclosporiasis outbreak in the US which has now been linked to two fatalities, and the funding cuts that threaten the iconic Jodrell Bank world heritage site, home to the Lovell telescope
Butterfly lilies wing their way to Science
Many animals and plants show left-right differences in how their bodies or organs are arranged, but we still know little about how such asymmetries evolve or how genes control them in natural populations. Mirror-image flowers, in which female and male sex organs are deflected to opposite sides in left- and right-handed forms, provide a notable example of such asymmetry. Here, we studied South African butterfly lilies, where individual plants produce only left- or right-handed flowers. Their mirror-image flowers promote outcrossing by depositing pollen from each floral form onto a specific region of a pollinator’s body that matches the stigma position of the opposite form. This suggests that selection for efficient pollen transfer between forms maintains this natural polymorphism. Our work uncovers a hemizygous supergene that coordinates the left-right orientation of female and male sex organs in mirror-image flowers by linking two independently acting genes for style and stamen handedness in a single, nonrecombining genomic segment. This architecture ensures the coinheritance of a matched pair of organ orientations that is essential for efficient cross-pollination between floral forms. At the developmental level, we show that floral handedness emerges from the interaction between an intrinsic tissue chirality and a gravitropic response that orients the style and median stamen relative to gravity. Together, these findings reveal how a supergene, hormone and microRNA signaling, tissue chirality, and an external physical cue combine to produce and maintain a stable left-right polymorphism in natural plant populations.
Digital Science brings real-world research impact data into AI workflows with new Altmetric MCP
Digital Science has announced the launch of its Altmetric MCP, a new Model Context Protocol server that connects AI agents to Altmetric’s research attention tracking data.
US Stand Up for Science movement expands to Europe
A grassroots movement by scientists in the US pushing back against threats to academic freedom is setting up a Swiss outpost to take the movement global. Stand Up for Science started in February 2025 to protest against politically-motivated grant cancellations by the Trump administration. Since then, it has organised numerous rallies by scientists and turned into a broader campaigning organisation, supporting “pro-science” political candidates and attempting to impeach Robert F. Kennedy Jr, the health and human services secretary the group accuses of advancing “quack” science. Now, Stand Up for Science is establishing a Swiss office to take some of its campaigning beyond the US, and its leader is urging European academics to organise similar pro-science groups in case they face similar threats in Europe. There will likely be “spillover” to Europe from what the Trump administration is attempting in the US, said Colette Delawalla, chief executive of Stand Up for Science, who last month returned from a tour of Europe. “Are we going to see a Trump-style scientific [. . .] take over in the same way?” she asked.Delawalla, who is doing a PhD in clinical psychology, said she was driven to help found the organisation after the Trump administration started cancelling health research grants in politically taboo topics, such as transgender people, diversity and HIV, in early 2025. Since then, the administration has introduced several other measures that infringe academic and institutional autonomy.It threatened to cut Harvard University’s federal funding unless the university accepted a “critical mass” of new faculty and students to create “viewpoint diversity.” And this year, it proposed explosive new rules that would allow political appointees at research funders to screen grants to make sure they “advance the president's policy priorities.”US scientists have been at times stunned by the volume of announcements, and the country’s researchers were relatively unprepared. “We sit in front of the fire hose every day,” said Delawalla. For this reason, European scientists need to prepare now for similar assaults. “If you've got a little bit of extra time to start thinking through, and making those preparations and building community and solidarity,” then European researchers will “start five steps ahead of where we were.” She plans to return to Paris in September to share experiences with concerned French academics. Is Le Pen the same?During her European tour, Delawalla said that French academics were beginning to worry about a National Rally (RN) victory in presidential elections next year. She said there were “chilling similarities” between Trump and Marine Le Pen, the RN’s likely candidate. However, so far, the RN hasn’t proposed anything nearly as radical as the Trump administration has carried out. Its current manifesto is all but silent on university and research policy. Le Pen’s 2022 manifesto bemoaned a lack of French R&D spending, including in fundamental research, and promised to modernise labs and strip away grant bureaucracy. The party’s 2024 European election manifesto explicitly supported the Erasmus+ student exchange programme, scientific exchange and joint European technology projects. However, a Le Pen victory next year could see France drastically cut its contribution to the EU, which would hit the budget for science and innovation. Meanwhile, more restrictive immigration policies could hit university recruitment of faculty and students. Climate science denial?As heatwaves and wildfires have ravaged France, the RN has sought to distance itself from previous comments casting doubt on climate science.In the UK, the radical-right party Reform UK, now second in the polls, denied climate research in a draft of its 2024 election manifesto, but its leader, Nigel Farage, then appeared to quietly U-turn and said he was “not arguing the science.” By contrast, Trump has repeatedly and explicitly denied climate change science, in 2025 calling it “the greatest con job.” Like the RN, Reform UK has been light on research and university policy. However, it did say in its 2024 manifesto that universities should suffer “heavy financial penalties” for allowing “political bias or cancel culture” on campus, building on laws brought in by a previous Conservative government. Ahead of September state elections in Saxony-Anhalt in Germany, the poll-leading Alternative for Germany has proposed abolishing gender studies and postcolonial studies, and promised money for “critical” climate research and studies of Islam. Starts with rhetoricEven if European radical right parties aren’t currently planning the draconian policy measures of the Trump administration, Delawalla said that academics should not be complacent, and fight even small funding restrictions or anti-science talk from the start. “It starts off with sowing distrust about institutions,” she said. “It starts off with these small things, and then all of a sudden it's there.” There are other, more established science and university advocacy groups in the US aside from Stand Up for Science. But the group stands out because of Delawalla’s refusal to attempt to appear politically bipartisan or conciliatory. “I firmly believe that the US is experiencing fascism,” she said. “We’re not trying to win over the super Maga people,” she said, “and we never have been.” The lesson of the US is that even if universities or other institutions capitulate to government demands, this doesn’t save them from cuts and restrictions. “It doesn’t matter what people do,” she said. Global “pseudoscience”Another aim of Stand Up for Science’s push into Europe is to better coordinate a campaign to protect people in poorer countries from what the group describes as “pseudoscientific exploitation,” trials outside the US used to build a case against things like vaccines. Earlier this year, the group sent an investigator to Guinea-Bissau to investigate a controversial, Danish-run Hepatitis B vaccine project funded by the US Centers for Disease Control and Prevention.The study would have withheld a proven vaccine from newborns, Stand Up for Science argued in a briefing it presented to Congress, risking their health. Significantly, the research group based in Guinea-Bissau, known as Bandim, focuses on the “non-specific effects” of vaccines: impacts on health beyond preventing the target disease. Related articlesEuropean researchers sound the alarm that Trump rule changes will hit cooperationData corner: which fields of health science is the US curbing? The US ‘golden age’ science strategy: what Europeans need to know The suspicion is that the study was funded as part of an attempt to shop around for results that could help build a case against vaccines in the US, said Delawalla. “This is just code for vaccines cause autism,” she said.Bandim has put out a rebuttal of Stand Up for Science’s criticisms, arguing its work has uncovered a number of vaccine side effects, both positive and negative, which need to be taken into account in public health. However, Congressional Democrats took up the Stand Up for Science cause, and in February, Guinea-Bissau said it had permanently halted the study. WatchdogBut for Delawalla, this is not the end of the fight. Kennedy has made a number of health claims that scientists think lack evidence, such as the idea that seed oils cause inflammation, for example. Delawalla worries that more studies could be launched in poorer countries to fish around for evidence to support this agenda. Stand Up for Science is talking to African science organisations to create a kind of “watchdog” to scrutinise any further trials. “Outsourcing the investigation to some of the most vulnerable children in the world who are desperate [. . .] is fundamentally wrong,” she said.
Why making Anthony Fauci the enemy will harm US public health for years
Republicans are trying to scapegoat the infectious disease expert, even as they have gutted healthcare amid outbreaks of measles, cyclosporiasis and Ebola
Panthers' Ainias Smith: Bound for IR
Panthers' Ainias Smith: Bound for IR
Dozens of new cyclosporiasis cases in Virginia and North Carolina; health officials warn about the risks
Bella Thorne’s ex taught her ‘how to be an adult’ amid hard times with mom
Bella Thorne credited ex-boyfriend Gregg Sulkin for teaching her key parts of adulthood at 18 after she moved out of her mom’s house.
Cyclosporiasis Map 2026, Foods to Avoid as Outbreak Spreads to 47 States
A massive outbreak of the “explosive diarrhea parasite” cyclospora has been linked to shredded lettuce. Where are cases rising, and what are the other possible sources?
Newcastle United appoint Matthias Jaissle as head coach following Eddie Howe's departure from St James' Park
Matthias Jaissle appointed new boss of Newcastle; German succeeds Eddie Howe after his resignation; Jaissle signs four-year deal at St James Park; Newcastle paid £9.5m compensation to Saudi side Al Ahli to appoint Jaissle, whose first match in charge of the Magpies is next Saturday
Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’
Sanofi halted a phase 2 trial testing a monoclonal antibody, SAR445399, in non-cystic fibrosis bronchiectasis, Fierce Biotech has learned. The trial, which began only back in April, was a randomized, double-blind, placebo-controlled study to measure the reduction in mucus plug score following treatment with SAR445399 compared with placebo in adults aged 18 to 80 years with NCFB, a chronic lung disease. The trial was officially reported as halted on July 29, the day before Sanofi’s second-quarter earnings call. The decision to pause the trial was made “as part of a company-wide portfolio review for strategic business reasons,” and not due to safety concerns, a Sanofi spokesperson told Fierce. The move to pause the NCFB trial comes during a trying time for Sanofi following a year filled with a series of trial fails. In February, the French pharma ousted CEO Paul Hudson and appointed Merck KGaA leader Belén Garijo, M.D., Ph.D., to steer the ship. Since then, Garijo has been doing a deep dive on correcting the company’s strewn R&D and clinical strategies. On July 24, Sanofi scrapped amlitelimab for atopic dermatitis, despite its lore as being a potential $5 billion blockbuster. During its second-quarter report, the company abandoned two more assets, balinatunfib and itepekimab, following failed trial results in psoriasis and chronic obstructive pulmonary disease, respectively. SAR445399, only first revealed by Sanofi in 2023, is an anti-interleukin-1 receptor 3 monoclonal antibody developed to block the interleukin 1, 33, and 36 cytokine pathways. These pathways can be important in chronic immune-related dermatologic diseases, such as atopic dermatitis and hidradenitis suppurativa, as well as respiratory conditions, such as NCFB. Related Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues NCFB affects roughly half a million people in the U.S., with a global incidence of greater than one million cases. In August 2025, Insmed received FDA approval for Brinsupri, a DPP1 inhibitor targeting neutrophil activation, for treatment of NCFB in adults and kids ages 12 and older. The British biotech Infex Therapeutics showed promising NCFB phase 2a data using their monoclonal antibody, INFEX702, which acts by disabling Pseudomonas aeruginosa, a bacteria known to be a major pathogen of NCFB. Sanofi is currently running a separate phase 2 study testing SAR445399 as a potential treatment for the inflammatory skin condition hidradenitis suppurativa.
Cyclosporiasis cases in Michigan climb to over 12,000, state health officials say
Michigan health officials reported 12,218 cases linked to an outbreak of cyclosporiasis on Wednesday, an increase of 710 cases since its last update a day earlier.
Cyclosporiasis Cases in Michigan Climb to Over 12,000, State Health Officials Say
Aug 5 (Reuters) - Michigan health officials reported 12,218 cases linked to an outbreak of cyclosporiasis on Wednesday, an increase of 710 cases since its last update a day earlier. Michigan has reported the first two deaths associated with the outbreak, saying both individuals had significant ...
The Science Lab Where Technicians Are Drowning in Feces
Samples—and a certain stink—are accumulating at Quest Diagnostics thanks to the cyclosporiasis outbreak. “You get used to it.”
Cyclosporiasis outbreak has expanded to six more states
The CDC’s planned update marks a significant expansion in the outbreak linked to shredded iceberg lettuce supplied by Taylor Farms.
Nurses chase cyclospora, aided by interviews, fast-food receipts
More than 900 people in Washtenaw County, Michigan, have been sickened with cyclosporiasis since mid-June. Linda Kim, a public health nurse, has called more than 100 of them. Almost everyone has said the same thing: It’s excruciating, and one of the worst illnesses they’ve experienced.
Procter & Gamble acquires Thorne for $3.8bn in bet on science-backed supplement growth
The deal, expected to close in Q4 2026, brings Thorne's clinically validated, practitioner-trusted supplement portfolio into P&G's consumer health stable — signalling mainstream consumer goods giants' accelerating move into premium VMS
A cafe with Latin flavor and doggie daycare call Jersey City home
New businesses opening in Jersey City are a cafe offering dishes of the Latin diaspora and the first New Jersey location for a canine daycare chain.
Canucks Could Have Interesting Comp for Petterson Trade
The Vancouver Canucks may have a comparable for a potential Elias Pettersson trade, as disappointing as it may seem. The post Canucks Could Have Interesting Comp for Petterson Trade appeared first on HEAVY.
Capital One dismissal bid puts Trump's JPMorgan Chase "political debanking" lawsuit in sharper focus
New filing in Trump's Capital One case spotlights the challenge of proving political bias when banks can broadly close accounts at their discretion.
In the Reflecting Pool fiasco, Trump’s ‘alternative facts’ again crash into reality
Jeanine Pirro faced a choice that all President Donald Trump’s team members confront sooner or later: Do they live in his world, or the real one?
OpenAI pays $3.2 million to settle US worker bias claim
OpenAI disputes the Justice Department's view, but said it wanted to move forward with a program to support employees "requiring immigration support."
These 10 wildflowers all have superpowers. Only one can win your vote
Move over waratahs and banksias! These 10 flowers from the unsung understorey are not just pretty faces, they have surprising tricks up their sleeves.
I Was Told I'm 'Just a Mom With a Side Hustle.' Here's What Those Words Reveal About Modern Business and Motherhood.
Motherhood is reshaping leadership, challenging outdated biases and redefining what it means to build a successful company.
Michigan health officials urge residents to keep eating fresh produce as cyclosporiasis outbreak continues
Kentucky health officials investigating over 600 reported cases of cyclosporiasis
The Kentucky Department for Public Health says they are investigating 620 reported cases of cyclosporiasis statewide, 274 of which have been confirmed as of July 29.
What to Eat and What to Avoid for Optimal Gut Health
Gut health can impact everything from sleep to the immune system, so Dr. Roshini Raj, associate professor of medicine at NYU Langone Health, shares her recommendations for preserving your gut microbiome. She shares the signs of an unhealthy gut, and what to eat to improve it. Dr. Raj also shares her tips for avoiding cyclosporiasis.
Wisconsin governor’s race tests limits of Democrats’ leftward shift
After years of Republican rule, Wisconsin Democrats are testing whether a democratic socialist is a viable candidate for governor in a swing state.
If Not AOC, Then Who?
What do we do if Alexandria Ocasio-Cortez decides not to run for president in 2028? It makes sense that many leftists are currently focused on calling on her to take the plunge. But the absence of a Plan B, or even much discussion about one, is worrisome. The US Left can’t afford to sit out the 2028 Democratic primary. Doing so in 2024 was a disaster: our abstention self-marginalized anti-billionaire politics from the national conversation and thereby gave space for Harris to pivot to the “center” (i.e. the policy preferences of corporate donors, establishment hacks, and AIPAC). Abstaining again in 2028 would be especially counterproductive since democratic socialists now have so much wind in our sails after our big electoral wins in NYC and across the country. It’s time to deepen our momentum, organization, and profile — not to retreat to the margins during America’s single most important political battle. Even more urgently, keeping Trump’s heir out of the White House may depend on whether leftists and the party’s unprecedentedly disenchanted base can force the Democrats in 2028 to take meaningful steps towards a very angry electorate and away from the corporate-consultant blob that has helped get us into this mess. If AOC (or Abdul El-Sayed) decides to run, we should enthusiastically go all in — DSA, fighting unions, progressive organizations, anybody who wants to see a better country and world. But, as far as I can tell from the outside, there’s a real chance that she doesn’t run. And we can’t just wait and see where she lands before discussing alternatives, since AOC’s decision might not come for quite a while, giving us little time to scramble at the last minute for an alternative. So we should start working now on getting a Plan B into motion, and recruiting a good candidate for the role. Here’s one idea. A Worker Candidate — Healthcare Not Warfare 2028 Run a union worker Leftists don’t need to always run experienced, well-known socialist politicians for high-profile contests. Lula, the current president of Brazil, began his political career as a metalworker militant who ran for governor of São Paulo in 1982. Especially in an era of institutional distrust, it’s possible to lean hard into making a virtue out of a working-class comrade’s distance from traditional politics. Experience abroad shows this clearly. Rachel Kéké — an immigrant hotel housekeeper — ran as the candidate of the leftist La France Insoumise for the National Assembly in 2022, defeating a former minister in the Macron government. The Belgian Workers’ Party in 2024 won its first Flemish seat in the European Parliament by running Rudi Kennes, a three-decade veteran of the Opel Antwerp auto factory. And the South Korean left in 2024 elected auto factory militant Yoon Jong-oh to the National Assembly. If a tiny French Trotskyist organization could make such a big splash in 2002 and 2007 by running a well-spoken postal worker cadre for office — the LCR’s Olivier Besancenot received about 1.5 million first-round votes — it’s not far-fetched to expect that a much larger organization like DSA, together with a broader coalition of the willing, could run this playbook to much greater effect. This is especially the case now that almost everything DSA does immediately becomes a national news story. We don’t need someone famous. We just need a charismatic, well-vetted comrade who works in a relatable working-class occupation — e.g. a nurse, or a worker in auto or construction, or at Amazon. Ideally, they have a compelling personal story or have been part of a significant strike or organizing campaign, but even those criteria don’t necessarily have to be deal-breakers. The main lesson of the Graham Platner fiasco isn’t that we should never run outsiders for office (the momentum he generated proves the exact opposite), but that they need proper vetting and roots in democratic membership organizations like DSA or a union. In any case, there are plenty of ways to signal working-class authenticity without resorting to Platner’s or Fetterman’s performative macho white dude affect. Better to have someone of any gender or race who is actually working class, with firm socialist politics, who can speak from experience about the day-to-day realities of trying to make it in America. There are surely at least a dozen such worker leaders in our movement nationwide; we just need to sit down and convince one that their personal sacrifice for the greater good (i.e. running for president) will be worth it. If we don’t have a frontrunner with a clear path to victory like AOC (or El-Sayed, were he to win Michigan), it’s better to embrace someone whose decision to run in itself tells an important story about US politics: workers have been iced out of our political system and are now fighting hard to break back in. The novelty factor, in itself, would generate press. And it would help democratic socialists signal to the American public that our movement’s defining characteristic is that we represent workers vs. bosses, not that we’re “the furthest left” force in American politics — a framework that suggests we’re extremists and that helps our opponents isolate us from non-college-educated voters by highlighting extremely minoritarian (and misguided) stances included in DSA’s platform like prison abolition. We don’t get many opportunities to speak to tens of millions of Americans; we need to use these opportunities to broaden our appeal beyond those already in our orbit. Run to polarize the 2028 primary and general election around “Medicare for All” and “End All Aid to Israel” Why should democratic socialists use our scarce time and volunteer energy to run in a race we’re unlikely to win? Running in the 2028 primary will not only recruit us scores of members (imagine having a DSA member intervening in eleven nationally televised primary debates!), but — more importantly — it has the potential to be a decisive leap forward towards an America that finally starts meeting the needs of working people instead of HMO and AIPAC billionaire donors. Polarizing litmus tests are good, actually — as long as they’re fought for around popular demands in a thoughtful and strategic way. Democratic socialists have an opportunity and responsibility to make the 2028 primary about two of the most widely and deeply felt issues of our moment: domestically, America’s unaffordable, family-breaking private healthcare system; internationally, America’s bankrolling of the genocidal Israeli government. A candidacy relentlessly demanding Medicare for All and No Aid to Israel would pose a sharp question to the American public, the Democratic Party, and other 2028 contenders: Why can’t working-class Americans afford their healthcare bills at the same time that our government is spending at least $3.8 billion yearly to fund an Israeli regime eager to keep dragging us and the world into more forever wars? Our candidate can agitate around a clear message: I’m running to give voice to all those working-class Americans who are struggling to get by. No matter what state you live in, who you voted for in 2024, or your background, it’s just plain common sense that we should make healthcare more affordable instead of spending billions to enable the Israeli government’s crimes against humanity. Every American who agrees with me when I say ‘Medicare for All — Not a Dime for Israel’ should make their voice heard through our campaign. Racking up a high number of votes for this agenda is a crucial way to show the Democratic Party and the country as a whole that we can’t keep supporting a life-destroying status quo in our healthcare system and in the Middle East. If we want to defeat Trump’s handpicked crony this coming November, we need to speak to ordinary people’s frustrations with the status quo — we can’t keep running the same tired establishment playbook and expecting a different result. For those highly engaged voters (or skeptical media pundits) who raise concerns about wasting votes, the candidate can take the time to explain why this isn’t the case: It's true I'm a long shot. But Zohran showed anything can happen — and voting for me is a pragmatic decision, not a wasted vote. In a heavily divided primary with a large number of candidates and a very discredited establishment, my campaign and the democratic socialist movement I’m part of are positioned to be the balance of power if we can get a large enough number of voters to loudly demand Healthcare Not Warfare. Since there’s a high chance no candidate will get to 50% in the 2028 primaries, the Democrats could very well be heading towards a brokered convention, where a disciplined, principled current committed to breaking from corporate donors can play an outsized role in making sure whoever ends up with the nomination raises the banner of single-payer healthcare and cutting aid to Israel. How exactly could running this sort of primary campaign be translated into actual leverage? The candidate replies: I’m aiming to win the nomination, but if I don’t achieve that goal, my delegates and I will pledge our support in the primary only for a candidate who agrees in the general election to call for ending US aid to Israel and establishing Medicare for All at home. These are both winning planks for November against the Republicans, and the only reason I can see that other candidates haven’t yet raised these is that they’re still more scared of the donor class than they are of the people. That needs to change. If Democratic leaders want young people, workers, and those sick of the status quo to show up in big numbers this November, they need to meet us halfway. In this way, whether or not we win the nomination, democratic socialists could still play a decisive role in 2028. The approach outlined here is similar to what radical left parties periodically do in parliamentary democracies like Denmark or Sweden when they find themselves as a junior partner electorally: they dictate to center-left allies what their terms would be for enabling, from the outside, the formation of a new government. Running a Healthcare Not Warfare candidate will make it significantly more likely that the 2028 Democratic candidate stands with ordinary people instead of donors on these two pivotal planks — a shift that will, in turn, make it easier to achieve the existentially important task of defeating MAGA’s heir in November. Look at how much popular traction the Uncommitted movement got with a similar strategy in 2024 with so little on-the-ground organization — surely we can go much further with a working-class candidate, a much bigger DSA, and a Democratic Party base that has turned against Israel, billionaires, and the hacks in the party who prop them up. Objections and Responses There are quite a few objections to this proposal, many of which are very reasonable. Let me briefly address each here. Socialists shouldn’t waste their scarce time and resources on a candidate unlikely to win. This is a good rule in general, but there are important exceptions, and presidential elections are the main one. There’s no other political contest that gets anything like this level of attention and engagement in the US, so if you want to be a serious force in nationwide politics, you basically can’t afford not to have a candidate. Far from being an overall drain on our resources, running a dynamic 2028 campaign would likely result in a major net increase in members and capacity. In that spirit, the very pragmatic Milwaukee sewer socialists — who mostly ran to win at home in Wisconsin — supported Eugene Debs’s propagandistic presidential campaigns, which they correctly saw as a crucial means of recruiting to the Socialist Party. And now that the (post-1972) Democratic Party gives more weight to voters than party operatives in determining its presidential nomination, it’s become feasible to run as a socialist in primaries without risking a split in the vote against the Republicans in November. We should just support Ro Khanna, who also supports M4A and ending aid to Israel. I like Ro Khanna and would enthusiastically vote and canvass for him for president were he to get the nomination. But there’s a real chance that Khanna’s bid for office doesn’t catch on; he lacks the grassroots organizational apparatus of DSA, and, because he’s not really of the Left or labor (despite his current very good positions), he’s unlikely to generate the type of buy-in and enthusiasm that a DSA candidate would. Moreover, Khanna would be running as an individual, not as someone emerging from and building an organized movement — his campaign would not likely focus on building sustained power from below, nor would it likely polarize the 2028 primary around M4A and Israel aid. Also, and not inconsequentially, the poor electoral results for Tom Steyer and Saikat Chakrabarti this spring suggest that there’s perhaps not much of a popular appetite in the Democrats’ base to support multi-millionaire class traitors. Much better, then, to run a democratic socialist worker. If by Super Tuesday it’s clear that our campaign has captured the main left lane in the primary, Khanna should drop out and endorse us; conversely, if he’s managed to capture this lane, DSA could at that point transform its Healthcare Not Warfare campaign into an independent campaign to elect Ro Khanna focused on winning (and holding him accountable to) those two critical planks. An openness to consolidating an anti-corporate candidate by Super Tuesday is a necessary component of the strategy I’m proposing, because otherwise we risk splitting the primary votes (per DNC rules, you need at least 15% to get any delegates to convention). We should convince Shawn Fain or Sara Nelson to run for president instead. I agree it’d be great if either ran for president, but my impression is that there’s basically no chance that will happen in 2028, because both are firmly focused on their union leadership duties (and, in the case of Fain, beating back a federal witch-hunt). This plan could have DSA end up endorsing a non-socialist, non-DSAer for president. That’s against our principles. It’s a myth, and bad politics, that socialists can’t ever support candidates who aren’t members of their organization and/or who don’t call themselves socialists. Bernie, after all, was not a DSAer. And socialists abroad regularly make tactical decisions about if and when supporting a non-socialist candidate makes sense from the standpoint of promoting working-class interests, defending democracy, and building a socialist current in the process. If your “principles” prevent you and DSA from helping achieve the momentous stride forward of having a Democratic candidate in 2028 run on Medicare for All and ending aid to Israel, those “principles” are not very good. In fact, they actively undermine the causes they’re aiming to support. We shouldn’t confuse principles (working-class independence) with tactics (the best way to advance this in a given context). In my recent article in Catalyst on Milwaukee sewer socialism (I’ve uploaded the full text here), I have a section showing how similarly rigid rules about endorsements had to be eventually discarded in the old Socialist Party nationwide after WWI because they tended to lead socialists towards a sectarian abstention from broader anti-corporate electoral insurgencies beyond their party’s control. For what it’s worth, Lenin’s current under Tsarism frequently backed bourgeois candidates in the second round of elections and Lenin himself advocated that British Communists support Labour Party candidates; for his part, Kautsky in 1912 defended the German Social Democracy’s electoral pact with the Progressives in the runoffs. If our predecessors could be that tactically flexible in an era before the limits of their underlying strategic assumptions about intransigent class politics in capitalist democracies were made clear, then there’s no need to insist on being more tactically rigid today, after a century’s worth of accumulated experience. As long as you maintain your own political profile and organization while engaging in broader coalitional efforts, there’s zero inherent contradiction with the principle of political independence. More specifically: DSA and allied organizations should enthusiastically back Michigan’s Abdul El-Sayed if AOC declines to run and he throws his hat in the presidential ring. (I have no idea whether he’s even considering this path, but there’ll surely be chatter about it if he wins his Senate race this November.) Though he doesn’t call himself a socialist, El-Sayed is a principled Berniecrat, a consistent fighter for Palestine, and would have a clear path to victory. Using the “s” word is far less important than whether a campaign fights for the interests of working people at home and abroad — and whether actively participating in it can grow the organized working class and the Left. And the same holds true if a less anti-corporate candidate were, under pressure, to adopt our two Healthcare Not Warfare planks. Why focus only on M4A and ending US aid to Israel? There are so many other important issues to fight for! Obviously there are many pivotal issues beyond healthcare and Israel, and our candidate — and especially our organizations involved in the campaign — should be prepared to speak on all of these. But one of the crucial lessons of the Zohran campaign is that you have to relentlessly stay on message if you want to cut through the noise. CNN and Fox News will want to talk about DSA’s views on Venezuela and abolishing the police; we need to polarize the debate on the widely and deeply felt issues that are most favorable for growing the Left, isolating our opponents, and winning urgently needed changes. One recent poll found 63% of Americans support M4A, even after respondents were told it would raise taxes and eliminate most private insurance. Another found that 74% of Democrats opposed “providing additional economic and military support to Israel.” And focusing on two demands sets the campaign up to be able to leverage its mandate to make clear demands upon other candidates (which we can’t do if we run with a laundry list of demands). Talking about a Plan B is a distraction from the more urgent work of building a groundswell of calls on AOC to run. It’s good for DSAers, fightback unionists, and progressive organizations to try to convince AOC to run. This proposal is meant as an addendum to pushes to get AOC to run and to line DSA up for that eventuality, not as a substitute for those efforts. But I’m worried that, like in 2024, we might eventually find ourselves with no time to find a viable alternative unless we start now. DSA, with its abundant deliberative processes, moves slowly. The approach you’re suggesting seems risky. If a DSA candidate runs but doesn’t receive a lot of votes, it’ll undercut our current national momentum. This is a reasonable worry. All big initiatives always carry risks, and the path I’m advocating is certainly not free of these. That said, if a Healthcare Not Warfare campaign doesn’t catch on like we envisioned, it’s a pretty simple pivot in March 2028 to explain that in the future we really need our standard-bearers like AOC, or our growing bench of national electeds, to step up in presidential primaries. Moreover, it’s worth noting that the risk of my Plan B proposal is on the whole significantly less than the risk entailed by an AOC run. We should all back her if she runs, since she’d fire up the base, provide huge openings for organizing, have a real shot at defeating a Republican (especially given MAGA’s unpopularity), be a great standard-bearer for our issues, particularly M4A and ending aid to Israel, and be less willing than mainstream candidates to capitulate to any anti-democratic machinations from Trump and co. But it’s also true that AOC could lose, which would be a devastating setback to the country and the Left. Or she could win and find herself unable to pass much, if any, of her (and our) program, a demoralizing prospect. So if we’re willing to take these risks with AOC (and we should), it follows that we should be able to take lower-level risks if she doesn’t throw her hat in the ring. What’s Your Plan B? The US Left is facing its biggest opening for growth and influence since the 1930s. Initiatives that would have been impossible a few months ago are now potentially feasible. A President AOC is now easier to imagine, but if she ultimately assesses that the risks aren’t worth the potential reward in 2028, we can’t be left flat-footed. So even if you’re not convinced by the specifics of my Plan B, I hope you can at least agree that it’d be a disaster for us not to have one — and not to start getting a Plan B into motion. Hopefully other organizers and political currents will put forward their responses and alternative ideas ASAP. The stakes are too high to just wait and see. More As always, please share this article widely. This newsletter depends on all you lovely people to get the word out. Thank you! I uploaded the full text of my Catalyst article on Milwaukee sewer socialism here (it’s updated and 3x as long as the version published earlier on this substack). If you haven’t yet, please make sure to subscribe to Catalyst here; I read every issue front to back, highly recommend. 🌹🎵 Ivan Lins (arranged by Arthur Verocai) — “General da Banda” 🌹🎵
First deaths reported in cyclosporiasis outbreak
Two people in Michigan have died in connection with the outbreak of cyclosporiasis, health officials reported Monday.
2 deaths reported in cyclosporiasis outbreak in Michigan as cases surpass 11,000
The first two deaths have been reported in the cyclosporiasis outbreak in Michigan, the state's health department announced Monday.
Michigan reports two deaths in cyclosporiasis outbreak
More than 11,000 cases of the foodborne illness have been confirmed in the state and 193 people have been hospitalized since early May.
Tuskegee University requires business suits, bans bonnets and du-rags in new dress code
Tuskegee University is implementing a new dress code requiring students to bring a business suit and dress shoes to campus while banning bonnets, du-rags and other non-religious head coverings in classrooms and cafeterias.
Secretary of State Alexi Giannoulias is running for mayor
Giannoulias sits on $22 million in campaign funds, roughly three times the total of his competitors.
Photo story: Science Saturday Connects Families with Nature Through Hands-On Learning
The Savannah River Ecology Laboratory (SREL) at the University of Georgia welcomed families, students, and nature enthusiasts to a successful Science Saturday on August 1st, 2026 at the Riverview Park Activities Center in North Augusta. Held from 10 a.m. to 1 p.m., the free community event brought together visitors of all ages for an fun […]
Scientists Discover New Dinosaur Species In Zimbabwe, Shed Light On Early Evolution
The newly identified species, Musango matusadonaensis, lived in what is now northern Zimbabwe during the Late Triassic period.
Nurses chase Cyclospora using grocery receipts, food apps and detailed interviews
Public health nurses have been pulled from other duties in Washtenaw County, MI, to call hundreds of people sick with cyclosporiasis, and try to help them remember everything they ate in recent days.
Gallery: Dias, Marmoush and Nunes arrive in Hong Kong!
Ruben Dias, Omar Marmoush and Matheus Nunes have all joined up with Enzo Maresca's squad in Hong Kong. Men's Team Donnarumma: We’re eager to show we’re ready Having had a three-week rest following...
Race Matters: When AI Learns Our Bias featuring Professor of Computer Science Ian Davidson
Artificial intelligence is rapidly becoming part of how we work, learn and make decisions. But AI doesn't think independently — it learns from the data and information people provide. As a result, these systems can reproduce or even amplify patterns of bias that already exist in society.
Miami University graduate develops app to provide transparency in politics
A Miami University graduate has developed an app to help voters access unbiased political information and make informed decisions ahead of elections.
ESPN’s SEC Bias Is Becoming Impossible to Ignore
Every offseason, college football fans argue over one thing more than anything else: SEC bias. And ESPN may have just poured gasoline on that fire. Earlier this week, ESPN Analytics revealed that every single SEC team has a preseason strength of schedule ranked inside the nation’s top 20. The explanation? The conference’s new nine-game league…
Machias Select Board approves liquor license for virtual sports business despite neighbors’ concerns
North Street residents object to a "bar" in their neighborhood, but town officials say a lack of zoning leaves them few grounds to deny it.
COVID’s political fallout still haunts both Democrats and Republicans
Unbiased Politics News
Video: Opinion | A Doctor Weighs In on the Health Tracking Craze
If a fitness enthusiast like Joe Rogan wants to scan his body ad nauseam to track his wellness, that’s fine, says Dr. Rachael Bedard on “The Opinions.” But using those scans to look for medical abnormalities can lead to costly, potentially harmful follow-up tests.
Cyclospora confusion? Four questions about the parasite in Minnesota, answered
Minnesotans can be reassured that the large multistate outbreak of cyclosporiasis infections, a gastrointestinal illness caused by cyclospora, has not yet reached the state.
The IAC and California-based Predictive Science Inc Predict the Solar Corona for the August 12 Eclipse Using the La Palma Supercomputer
Ahead of the upcoming solar eclipse on August 12, the Instituto de Astrofísica de Canarias (IAC), in collaboration with the research group Predictive Science Inc. (PSI, San Diego, California), has successfully simulated in high detail the structure of the solar corona that will be visible during totality along the path of totality, including Palencia, where the IAC will gather more than 40 spanish, moroccan, and american astronomers.
Kamala Harris' new $8M mansion is in a neighborhood with virtually no Black residents
Kamala Harris' $8 million Malibu mansion sits in a census tract that is 94% White and 0.2% Black, despite her career fighting racial bias in housing.
Mississippi sees rise in cyclospora cases, health official weighs in
Mississippi health officials report rise in cases of cyclosporiasis. How to protect yourself from the diarrhea-causing parasite.
From bad to worse for Trump and his base
Republicans are starting to fret about their base’s lack of enthusiasm ahead of the 2026 midterm elections.
Press Release: Rowan County Public Health Confirms First Case of Cyclosporiasis
Rowan County Public Health Confirms First Case of Cyclosporiasis FOR IMMEDIATE RELEASE Salisbury, NC-Rowan County Public Health (RCPH) is investigating our first confirmed c
Cyclosporiasis Outbreak 2026 Map, Foods to Avoid as Parasite Cases Hit 45 States
A massive outbreak of the “explosive diarrhea parasite” cyclospora has been linked to shredded lettuce. Where are cases rising, and what are the other possible sources?
Pokémon Pokopia's First DLC Comes To Switch 2 On August 5
There's a new underwater location to explore and a dive mechanic.
The Trump Administration Is Changing Our Military Academies for the Worse, and I’m Afraid of the Consequences
A recent free speech fiasco at West Point is just the beginning.
The Science Behind the AI Panic Is Shakier Than You Think
A column by Sascha Lobo Is AI making us dumb? So asked DER SPIEGEL on its cover a while ago. After a few weeks of recovery and a therapeutic intervention with the help of my AI, I feel able to respond. That’s a bit unfair, of course; the article itself is more nuanced than the loud cover, the image of a schoolkid with dull prompt questions, or the subtitle: “AI is conquering the schools, and educators fear a disaster.” The short answer to “Is AI making us dumb?” is: no. The long answer is more interesting, and even carries a preliminary glimmer of the spectacular. Unfortunately, it requires a detour into the sphere of artificial intelligence, into the mogul-field terrain of technology assessment, the attention economy, and the destructive virus of cultural pessimism. Along with narrowing the scope to AI’s effects on education and work rather than on intelligence. Because the honest version of the question would be: Does AI help us learn and work, or not? Generative AI, which set off the still-ongoing hype with ChatGPT, has only existed in relevant distribution since late 2022, early 2023. For a technology-driven transformation of people and society, that is extremely short. For that reason alone, research is still in its infancy. And technology assessment is not a fast discipline anyway. Prominent voices from Elizabeth Eisenstein to RAND to Tom Wheeler say we still cannot conclusively judge the consequences of the printing press. Its invention is a mere 580 years back, and some scholars would rather not circulate assessments that might have to be retracted in two or three hundred years. We’re Going Through Growing Pains A phenomenon that already caused upheaval in social media research makes serious assessment of AI’s consequences even harder: the “moving target” problem of LLM-ology, as the linguist Sean Trott called it in 2025. AI develops so quickly and so unpredictably that researchers often end up studying snapshots of the past. There are concepts, from morphological analysis to anticipatory governance, for keeping research, planning, and regulation halfway meaningful anyway. But even with those, universally valid statements are rare. DER SPIEGEL - The German View is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber. Subscribe We should therefore treat findings about the interplay between humans and AI as far more procedural and situational. Unfortunately, this challenge comes at the worst possible time. We are going through growing pains: AI’s everyday impact has grown very large very fast, and with it the longing for guidance. Annoyingly, the body of solid knowledge has not exploded along with it. Experts cannot be moved to broad consensus on even banal statements about AI. Sascha Lobo, born in 1975, is an author and strategy consultant focusing on the internet and digital technologies. Together with Jule Lobo, he explores the debates of the day in the podcast “Feel the News – Was Deutschland bewegt” (”What Moves Germany”). Nvidia CEO Jensen Huang says software developers are dying out. Bill Gates considers coders one of only three professions that will survive the AI tsunami. Top tech economists find virtually irrefutable arguments both for and against an AI bubble. The same naturally applies to the structurally youth-hostile debate over whether AI is good or bad for young people. The gap between the demand for insight and the supply of solid knowledge creates an orientation vacuum. This vacuum of AI cluelessness is filled, as the attention economy described by Georg Franck in 1998 would have it, with half-knowledge (funnily enough, often AI-generated), marketing, and self-marketing. After all, infinite money is at stake, along with academia’s best current shot at global fame. But this iridescent froth of interpretation operates more by the algorithmic principles of the digital public sphere than by seriously earned insight. That is why dramatized, fear-feeding claims about AI are so promising. It tempts parts of academia into distorted drivel, and parts of the media then sensationalize the published drivel once more. Was the Research Aimed at a Desired Result? How badly this can influence academia and public perception is demonstrated by one of the most-discussed studies on AI’s effects: “Your Brain on ChatGPT.” The MIT study by Nataliya Kosmyna also gets plenty of space in the SPIEGEL cover story. What was measured and interpreted: lower brain activity in people who write with AI assistance, compared to people who only google or write without any tools. As is common with preprints, the study has not yet been peer-reviewed, and it contains substantial weaknesses that experts have sharply criticized. The first round had 54 participants in three groups, the second only 18, who reportedly also came from MIT’s own orbit. There was no preregistration (committing in advance to what you want to find out with which data). In their analysis, Stanković et al. even discovered an opposite effect that the study does not further explain. Some measurement data has not (yet) been published. And the EEG analysis method used is considered too imprecise to support such far-reaching conclusions. The biggest criticism, though, is the suspicion of an activism-driven study. In an interview with Time, lead author Kosmyna said she published the study immediately, rather than after full peer review, because she feared politicians might otherwise decide to put ChatGPT in kindergartens. She considers that absolutely harmful. It is legitimate to hold such a view. It just seems unscientific to approach a study with it, and then to design the setup so that the chance of a fitting desired result remains as high as possible. Ideologies Collide It is not easy to separate genuine AI insights from studies that trivialize and weaken well-founded AI criticism. The same goes for the opposing, AI-enthusiastic narratives, because the pro-AI side works against it with billions in resources. Ideologies collide, fed by egos, PR strategies, moral posturing, and once-in-a-lifetime opportunities. Doomsday marketing makes the search even harder: AI companies can profit from warnings about the dangers of AI, whether through the notoriety of apocalypse narratives or because, in some target groups, danger translates into power. Some seemingly negative findings are therefore quite welcome in the AI industry. If you try to get at the findings presumably less influenced by interest groups, the picture in education seems relatively clear: AI can improve educational outcomes when the right AI is used the right way, namely pedagogically. Simply dumping an AI chatbot into a classroom, by contrast, accomplishes little. Huge surprise. But something else is also obvious: whether they are allowed to or not, kids use AI for school, which is why the controlled integration of AI tools into education is, in the medium term, entirely without alternative. In the world of work, the landscape of findings is more complex and requires more differentiation. A series of serious studies points to an AI effect that suits neither the alarmists, regulation fetishists, and AI opponents, nor the trillion-dollar corporations with their armada of paid scientists, PR professionals, and ecosystems: working with AI helps the inexperienced (at least for now) considerably more than it helps the pros, in certain fields of work, and provided they know how to use it correctly. Missing Domain Knowledge Among the experienced, the professionals, and the high flyers, by contrast, despite frequent time savings, partially negative effects and new problems are emerging. Take the jagged frontier problem: AI solves task A brilliantly and fails completely at task B, even though both look similar even to professionals. Or the verification-cost problem, in which AI’s greater productivity gets eaten up by the enormous effort of checking its output. Or the illusion of competence, because AI makes new domains seem easily penetrable, until you painfully discover that deep domain knowledge is missing. Taken as a whole, the effects of working with AI do lean positive. But the promise that AI works as a turbocharger for everyone and boosts practically everything simply refuses to materialize. The AI magic the world has been feeling since ChatGPT arrived in late 2022 has so far barely shown up in most companies’ numbers. The consulting firm McKinsey has coined a term for this, the “gen AI paradox,” and believes that work processes and corporate structures would have to be rebuilt quite fundamentally to realize AI’s benefits at scale. Reuters just reported that only 3.3 percent of Microsoft’s customers have subscribed to the AI package Copilot. That may be down to the product; in other areas we continue to see soaring successes and new AI triumphs. But after the first quarter of 2026, disillusionment is the word for all too many AI projects at traditional companies: because the promised revolution of AI agents has so far failed to arrive or been postponed, and because of the leveling effect that many of the studies cited here suggest. Against Inequality The societal effects, on the other hand, appear rather encouraging. Many previous technologies operated on the Matthew principle, named for the Gospel verse about giving to those who already have: they tended to reward the more competent and more privileged. AI, however, seems more often to have an equalizing effect once a threshold of access and education is crossed. Some anecdotal insights point in this direction, for example, how an unemployed man in Leipzig successfully defended himself in court in 2025 against fraud accusations from Germany’s federal employment agency — without a lawyer, armed only with ChatGPT. The AI made mistakes and cited invented court rulings, but in the end the man walked away unpunished. And a key capability of artificial intelligence is its capacity to learn: set up correctly and fed with data, it can keep getting better. It is a question of time, or more precisely of AI innovations and training data, until even free AI chatbots write better legal briefs than law graduates with perfect exam scores. Whether that will make anyone dumb is something the world’s press will surely inform us of in due time. Subscribe Leave a comment
A new media ecosystem is taking root on the left, reshaping Democratic politics
NEW YORK (AP) — Farah Berent, a teacher in Michigan, used to learn about politics from channels like ABC, CBS and CNN. But that changed as she decided that coverage of the war in Gaza was irreparably biased.
Michigan cyclospora outbreak shows signs of improvement as new cases slow
Nationwide, there are more than 18,000 confirmed or suspected cases of cyclosporiasis, the illness caused by a parasite found in human feces, the CDC said Tuesday.
More than 700 cyclosporiasis cases reported in North Carolina: health officials
WLOS News 13 provides local news, weather forecasts, traffic updates, notices of events and items of interest in the community, sports and entertainment programming for Asheville, NC and nearby towns and communities in Western North Carolina and the Upstate of South Carolina, including the counties of Buncombe, Henderson, Rutherford, Haywood, Polk, Transylvania, McDowell, Mitchell, Madison, Yancey, Jackson, Swain, Macon, Graham, Spartanburg, Greenville, Anderson, Union, Pickens, Oconee, Laurens, Greenwood, Abbeville and also Biltmore Forest, Woodfin, Leicester, Black Mountain, Montreat, Arden, Weaverville, Hendersonville, Etowah, Flat Rock, Mills River, Waynesville, Maggie Valley, Canton, Clyde, Franklin, Cullowhee, Sylva, Cherokee, Marion, Old Fort, Forest City, Lake Lure, Bat Cave, Spindale, Spruce Pine, Bakersville, Burnsville, Tryon, Columbus, Marshall, Mars Hill, Brevard, Bryson City, Cashiers, Greer, Landrum, Clemson, Gaffney, and Easley.